Clinical Trial Update: A Study of VLX1570 and Dexamethasone in Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study of VLX1570 in combination with dexamethasone for multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• VLX1570

Snippet

Sponsor: Vivolux AB | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED